PHAR

11.5405.18%
LM

Leverne Marsh

Co-CEO & Chief Commercial Officer

Ms. Leverne Marsh, BPHARM, was Executive Vice President of Marketing of DexCom, Inc. from February 2024 until 2025. She serves as Chief Commercial Officer at Pharming Group N.V. since January 1, 2026 and serves as Co-Chief Executive Officer since September 29, 2026. She joined Dexcom from Novartis Pharmaceuticals where she served as Chief Product Officer and SVP of Pharma Strategy and General Management for in the United States. In this role, she was responsible for a significant P&L and led a team of general managers across the therapeutic areas of immunology, neuroscience, cardiology, nephrology, respiratory, ophthalmology business divisions.She currently serves on the Board of Trustees for Saint Vincent Academy, a private girls Catholic school serving underserved communities in Newark, New Jersey. She resides in New Jersey with her husband Andrew and stepdaughter Andrea; along with Atticus the Cat and they enjoy spending spend their time between the US and South Africa where she still has deep family roots.Her educational background includes a degree in pharmacy from the Nelson Mandela Metropolitan University in South Africa, giving her a strong foundation in the healthcare field. She is also a Chartered Marketer, a testament to her understanding of marketing principles and her ability to use these skills in marketing and communication to achieve business goals.

Positions